Parainfluenza 4 BY PCR

The Parainfluenza 4 BY PCR test is a molecular diagnostic assay that detects genetic material (RNA) of human parainfluenza virus type 4 using a nasopharyngeal or oropharyngeal swab. Performed via real-time PCR, it provides high-sensitivity, specific detection to confirm active infection and can report cycle threshold (Ct) values for clinical interpretation. This service includes convenient home sample collection across Dubai and the UAE, with fast turnaround to support timely clinical decisions for children, older adults, and immunocompromised patients.

• Parainfluenza 4 RNA — Qualitative
• Cycle threshold (Ct) value
• Result interpretation — Detected / Not detected
• Sample type — Nasopharyngeal / Oropharyngeal swab
• Internal control (sample adequacy)

• Acute respiratory symptoms: fever, cough, sore throat or wheeze
• Infants and young children with bronchiolitis or suspected viral pneumonia
• Immunocompromised patients with new respiratory symptoms
• Close contact with a confirmed parainfluenza case or during institutional outbreaks
• Prior to hospital admission or respiratory procedures for infection-control decisions

• High-sensitivity molecular detection for accurate diagnosis
• Rapid and reliable results to guide treatment and isolation
• Professional home sample collection across Dubai and the UAE
• Supports outbreak management and reduces unnecessary antibiotic use
• Laboratory report includes Ct value and interpretative guidance

• At-home nasopharyngeal or oropharyngeal swab collected by a trained technician
• Refrain from using nasal sprays or heavy nasal decongestants for 2 hours before sampling
• Have Emirates ID or passport and recent symptom onset information available
• Inform the technician of current antiviral, steroid, or immunosuppressive medications